Posted by Michael Wonder on 07 Jun 2017
Cancer Drugs Fund of minimal benefit
6 June 2017 - A new study has concluded that the medicines available in the previous version of the NHS Cancer Drugs Fund, which ran from 2010–16 and cost a total of £1·27 billion, were largely of minimal benefit.
